1. Home
  2.  » 
  3. Expert Content
  4.  » 
  5. Cell Therapy
  6.  » Manufacturing Considerations for Mesenchymal Cells and Broader Allogeneic Modalities

Manufacturing Considerations for Mesenchymal Cells and Broader Allogeneic Modalities

Summary: Mesenchymal Cell (MSCs) therapies are being pursued in high-impact diseases, but scalability is still a challenge. At Catalent, we implement innovative manufacturing and fill & finish methodologies to accelerate the path to commercial for MSCs and other allogeneic modalities.

 

Click here to download the Webinar